LAZARD ASSET MANAGEMENT LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 156 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$86,000
+28.4%
3,061
+0.2%
0.00%
Q2 2022$67,000
-20.2%
3,054
+4.2%
0.00%
Q1 2022$84,000
+21.7%
2,930
+37.9%
0.00%
Q4 2021$69,000
-28.9%
2,125
+0.6%
0.00%
Q3 2021$97,000
-32.6%
2,113
-19.7%
0.00%
Q2 2021$144,000
+7100.0%
2,630
+5160.0%
0.00%
Q1 2021$2,0000.0%500.0%0.00%
Q4 2020$2,000
-98.4%
50
-97.9%
0.00%
Q2 2020$125,000
+71.2%
2,341
+12.7%
0.00%
Q1 2020$73,000
-88.9%
2,078
-85.5%
0.00%
-100.0%
Q4 2018$659,000
-40.2%
14,3000.0%0.00%
-50.0%
Q3 2018$1,102,000
-73.3%
14,300
-70.9%
0.00%
-71.4%
Q2 2018$4,134,000
+77.2%
49,087
+72.0%
0.01%
+75.0%
Q1 2018$2,333,000
+4.3%
28,532
-27.1%
0.00%0.0%
Q4 2017$2,237,000
-36.3%
39,136
-25.7%
0.00%
-33.3%
Q3 2017$3,514,000
+131.8%
52,659
+78.6%
0.01%
+100.0%
Q2 2017$1,516,00029,4800.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Eagle Health Investments LP 431,413$12,558,0003.09%
Casdin Capital, LLC 2,090,000$60,840,0002.73%
Rock Springs Capital Management LP 2,665,275$77,586,0001.95%
Bellevue Group AG 4,129,292$120,204,0001.40%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,177,374$34,273,0001.05%
Altium Capital Management LP 66,196$1,927,0000.64%
ArrowMark Colorado Holdings LLC 1,295,948$37,725,0000.33%
FARALLON CAPITAL MANAGEMENT LLC 1,333,012$38,804,0000.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 21,500$707,0000.16%
Virtus ETF Advisers LLC 11,541$336,0000.15%
View complete list of AGIOS PHARMACEUTICALS INC shareholders